Susquehanna International Group’s Medifast MED Stock Holding History

Susquehanna International Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.44M	Buy	435,400 +296,100	+213%	+$3.19M	﹤0.01%	4457
2025 Q4	$1.49M	Sell	139,300 -474,100	-77%	-$5.67M	﹤0.01%	6276
2025 Q3	$8.39M	Sell	613,400 -81,800	-12%	-$1.14M	﹤0.01%	3271
2025 Q2	$9.77M	Buy	695,200 +508,500	+272%	+$6.68M	﹤0.01%	2866
2025 Q1	$2.52M	Buy	186,700 +54,900	+42%	+$825K	﹤0.01%	5025
2024 Q4	$2.32M	Sell	131,800 -48,200	-27%	-$894K	﹤0.01%	4968
2024 Q3	$3.45M	Buy	180,000 +78,300	+77%	+$1.51M	﹤0.01%	4290
2024 Q2	$2.22M	Buy	101,700 +18,900	+23%	+$504K	﹤0.01%	4898
2024 Q1	$3.17M	Buy	82,800 +31,200	+60%	+$1.51M	﹤0.01%	4417
2023 Q4	$3.47M	Buy	51,600 +5,200	+11%	+$362K	﹤0.01%	4329
2023 Q3	$3.47M	Buy	46,400 +3,300	+8%	+$293K	﹤0.01%	4131
2023 Q2	$3.97M	Buy	43,100 +18,400	+74%	+$1.64M	﹤0.01%	3899
2023 Q1	$2.56M	Sell	24,700 -2,800	-10%	-$310K	﹤0.01%	4638
2022 Q4	$3.17M	Sell	27,500 -3,300	-11%	-$384K	﹤0.01%	3923
2022 Q3	$3.34M	Buy	30,800 +6,300	+26%	+$903K	﹤0.01%	3867
2022 Q2	$4.42M	Buy	24,500 +1,300	+6%	+$233K	﹤0.01%	3387
2022 Q1	$3.96M	Buy	23,200 +1,200	+5%	+$226K	﹤0.01%	4085
2021 Q4	$4.61M	Sell	22,000 -1,100	-5%	-$227K	﹤0.01%	3887
2021 Q3	$4.45M	Buy	23,100 +2,400	+12%	+$590K	﹤0.01%	4173
2021 Q2	$5.86M	Buy	20,700 +11,200	+118%	+$3.03M	﹤0.01%	3734
2021 Q1	$2.01M	Sell	9,500 -110,500	-92%	-$26.4M	﹤0.01%	5904
2020 Q4	$23.6M	Sell	120,000 -48,600	-29%	-$8.59M	﹤0.01%	1564
2020 Q3	$27.7M	Buy	168,600 +135,300	+406%	+$22.3M	0.01%	1226
2020 Q2	$4.62M	Buy	33,300 +500	+2%	+$45.9K	﹤0.01%	3109
2020 Q1	$2.05M	Sell	32,800 -29,600	-47%	-$2.69M	﹤0.01%	3928
2019 Q4	$6.84M	Sell	62,400 -12,100	-16%	-$1.17M	﹤0.01%	2544
2019 Q3	$7.72M	Sell	74,500 -87,200	-54%	-$9.37M	﹤0.01%	2236
2019 Q2	$20.7M	Buy	161,700 +120,900	+296%	+$16.8M	0.01%	1248
2019 Q1	$5.2M	Buy	40,800 +17,100	+72%	+$2.17M	﹤0.01%	2404
2018 Q4	$2.96M	Sell	23,700 -20,700	-47%	-$3.54M	﹤0.01%	2958
2018 Q3	$9.84M	Sell	44,400 -5,500	-11%	-$1.12M	﹤0.01%	1958
2018 Q2	$7.99M	Buy	49,900 +6,400	+15%	+$818K	﹤0.01%	2170
2018 Q1	$4.07M	Buy	43,500 +18,300	+73%	+$1.37M	﹤0.01%	2803
2017 Q4	$1.76M	Buy	+25,200	New	+$1.67M	﹤0.01%	4143
2017 Q3	–	Sell	-40,000	Closed	-$1.66M	–	9303
2017 Q2	$1.66M	Buy	40,000 +28,600	+251%	+$1.24M	﹤0.01%	4262
2017 Q1	$506K	Buy	+11,400	New	+$491K	﹤0.01%	6468
2016 Q4	–	Sell	-10,500	Closed	-$397K	–	9901
2016 Q3	$397K	Buy	10,500 +4,200	+67%	+$151K	﹤0.01%	6478
2016 Q2	$210K	Buy	+6,300	New	+$203K	﹤0.01%	7535
2015 Q1	–	Sell	-47,600	Closed	-$1.6M	–	9702
2014 Q4	$1.6M	Sell	47,600 -67,300	-59%	-$2.1M	﹤0.01%	4911
2014 Q3	$3.77M	Buy	114,900 +91,600	+393%	+$2.81M	﹤0.01%	3471
2014 Q2	$709K	Sell	23,300 -6,100	-21%	-$190K	﹤0.01%	6786
2014 Q1	$855K	Sell	29,400 -15,900	-35%	-$426K	﹤0.01%	5780
2013 Q4	$1.18M	Buy	45,300 +14,900	+49%	+$382K	﹤0.01%	5201
2013 Q3	$818K	Buy	30,400 +7,900	+35%	+$211K	﹤0.01%	5652
2013 Q2	$580K	Buy	+22,500	New	+$591K	﹤0.01%	5835

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Susquehanna International Group's MED Position: Q3 2025 in Review

Susquehanna International Group sold out of Medifast (MED) in Q3 2025, closing a stake of 29,501 shares — an estimated $412K sold.

Susquehanna International Group first reported a position in MED in Q3 2013 and held it in 37 quarters. The position peaked at $4.7M in Q2 2024. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

Susquehanna International Group reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 29,501 Medifast shares in Q3 2025, an estimated $412K.
Susquehanna International Group first reported a position in Medifast in Q3 2013 and held it in 37 quarters.
Susquehanna International Group's Medifast position peaked at $4.7M in Q2 2024.
123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.